British American Tobacco Finalizes July 2026 Buyback, Acquiring 585,804 Shares Over Five Days

Structured Five-Day Share Repurchase Across LSE and Alternative Trading Venues

Between 13 and 17 July 2026, British American Tobacco executed its share buyback programme through multiple authorised platforms including the London Stock Exchange (LSE), CHIX, and BATE. This multi-venue strategy aligns with contemporary equity market practices, where institutional purchases are distributed across venues to mitigate execution risk and reduce market impact. UBS AG London Branch served as the executing broker for BAT's capital management initiative.

Detailed daily transaction data reveals that on 13 July 2026, BAT acquired 146,565 shares at a volume-weighted average price of 4,405.86 pence per share. Subsequent purchases on 14, 15, and 16 July were made at average prices of 4,381.23, 4,369.80, and 4,431.12 pence respectively. No purchases occurred on 17 July 2026. This phased approach demonstrates a disciplined execution strategy aimed at securing efficient pricing while adhering to regulatory buyback programme requirements.

Capital Structure Update Following Planned Share Cancellation

Following this buyback tranche and the intended cancellation of repurchased shares, British American Tobacco updated its capital structure. The company now has 2,163,693,936 ordinary shares issued (excluding treasury shares) with full voting rights, alongside 132,654,339 shares retained in treasury. These figures are crucial for shareholders as they determine voting power and the company’s authorised capital base. The cancellation permanently removes shares from issued capital, differentiating it from treasury shares which remain available for future reissuance.

Disclosure of these post-transaction figures complies with the FCA's Disclosure Guidance and Transparency Rules, enabling shareholders to evaluate notification threshold crossings. This is especially relevant for institutional investors monitoring beneficial ownership, as the share reduction proportionally increases existing shareholders’ voting power. The 132.7 million treasury shares represent a significant reserve for future corporate actions such as employee share awards or capital-light acquisitions.

Shareholder Approval and Regulatory Compliance Governing the Buyback

The buyback programme is authorised by BAT shareholders from the Annual General Meeting held on 15 April 2026. Such shareholder approval is mandatory for UK-listed companies to set buyback limits and permissible price ranges. Initially announced on 18 March 2024, the multi-year capital allocation framework grants management flexibility to execute repurchases opportunistically based on market conditions and business performance.

The programme’s execution complies with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK, requiring comprehensive disclosure of each transaction’s venue, volume, and price. Detailed transaction schedules filed with the Regulatory News Service ensure transparency, preventing market abuse and confirming that buybacks occur at fair market prices without manipulation.

Multi-Venue Trading and Pricing Efficiency Analysis

Transaction data indicates BAT’s purchases were spread across the London Stock Exchange, CHIX, and BATE venues. The LSE accounted for approximately 462,159 shares, CHIX for about 69,615 shares, and BATE for roughly 24,561 shares over the five days. This distribution reflects the European equities trading landscape, where the primary listing venue attracts the majority of order flow, while alternative venues provide additional liquidity sources.

Price fluctuations during the period were modest, with the highest volume-weighted average price at 4,431.12 pence on 16 July and the lowest at 4,369.80 pence on 15 July, a range of around 61 pence or 1.4%. Daily volumes ranged from 144,610 shares on 16 July to 146,855 shares on 15 July, indicating disciplined execution designed to maintain consistent participation without undue market disruption. The overall pricing and execution adhered to Regulation 596/2014 disclosure requirements.

British American Tobacco’s Global Market Position and Strategic Outlook

Headquartered in London, British American Tobacco operates in over 180 markets worldwide, manufacturing and distributing conventional cigarettes, cigars, heated tobacco products, and emerging non-combustible nicotine delivery systems backed by substantial R&D investment. The company’s portfolio includes renowned brands such as Dunhill, Pall Mall, and Rothmans. With revenues exceeding £25 billion in recent years, BAT ranks among the largest global tobacco companies by market capitalisation and revenue.

The buyback programme aligns with BAT’s long-term capital allocation strategy. Tobacco firms like BAT generate significant free cash flow due to high margins and capital-light operations, enabling substantial shareholder returns through dividends and share repurchases. Announced in March 2024, the buyback programme formalises BAT’s commitment to returning capital, complementing its dividend policy. The July 2026 tranche execution reflects management’s confidence in deploying capital at attractive valuations within market and regulatory constraints.

Regulatory Challenges and Capital Allocation Considerations in the Tobacco Sector

The tobacco industry faces tightening regulations in developed markets, including higher excise taxes, plain packaging laws, advertising bans, and public health initiatives, creating long-term volume and pricing uncertainties. BAT’s ongoing buyback commitment signals confidence in sustaining cash flows to support dividends and discretionary repurchases despite these headwinds. Regulatory pressures also necessitate balancing capital between shareholder returns and investment in product innovation, especially in non-combustible nicotine categories.

BAT confronts regulatory risks related to nicotine product oversight, with potential future restrictions on traditional tobacco and evolving standards for heated tobacco and vapor products. Divergent EU and UK regulatory frameworks post-Brexit add complexity for the UK-listed global company. These evolving regulations may require significant capital reallocation toward product development and compliance, potentially limiting future buyback capacity. Investors should consider BAT’s buyback programmes within the context of its product portfolio transition and regulatory risk management.

Voting Rights Impact and Shareholder Disclosure Obligations

The buyback completion and share cancellation affect shareholders’ voting power in BAT’s governance. The disclosed post-transaction issued share capital of 2,163,693,936 shares enables shareholders to calculate their updated voting percentages. Under FCA Disclosure Guidance and Transparency Rules, significant shareholders must notify changes crossing thresholds (e.g., 3%, 5%, 10%). The reduction in issued shares may cause some shareholders to cross notification levels if their holdings remain unchanged in absolute terms.

The announcement reminds shareholders to verify compliance with notification requirements. Treasury shares (132,654,339) lack voting rights and are excluded from issued share capital calculations, a key distinction for disclosure purposes. Institutional investors with substantial BAT stakes should reassess their holdings against the updated issued share capital to ensure regulatory compliance and avoid penalties or trading restrictions.

Regulatory Filings and Market Execution Transparency

The announcement references detailed transaction schedules filed via the Regulatory News Service, documenting every trade executed by Merrill Lynch International, the executing counterparty, during the buyback period. These public records specify venue (LSE, CHIX, BATE), share quantity, and execution price. This granular disclosure complies with Article 5(1)(b) of the Market Abuse Regulation, providing an audit trail that prevents conflicts of interest or non-arm’s length pricing between BAT and brokers. Market participants can assess execution quality and fairness through these filings.

Multi-venue execution data reflects trading across primary and secondary markets within the Multilateral Trading Facilities framework prevalent in European equities. Each venue offers unique order flow and liquidity characteristics, influencing execution prices due to market microstructure factors. The published volume-weighted average prices allow investors to benchmark execution efficiency against alternative strategies or historical performance, aligning with regulatory expectations for institutional transactions.

Outlook on Capital Management and Investor Guidance

Completion of this July 2026 buyback tranche preserves BAT’s flexibility for future repurchases under shareholder-authorised limits from the April 2026 AGM. Additional tranches may be executed opportunistically based on market valuations, regulatory compliance, and financial results. The staggered approach observed in July 2026 indicates a preference for measured, disciplined execution over aggressive buying, mitigating market timing and execution risks.

No forward guidance on timing, scale, or pricing for future buybacks was provided, consistent with UK-listed company practices to maintain board discretion. Investors seeking insight into BAT’s long-term capital allocation should monitor forthcoming financial reports, investor presentations, and AGMs. The ongoing buyback programme initiated in March 2024 remains active, with further tranche announcements expected periodically, supporting a steady shareholder return strategy combining dividends and buybacks.